Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2007 057 999.6 |
96 | EP file number | EAKZ | 15 19 9395.3 |
97 | EP publication number | EPN | 3034607 |
54 | Designation/title | TI | PROTEASEABTASTVERFAHREN UND DAMIT IDENTIFIZIERTE PROTEASE |
51 | IPC main class | ICM (ICMV) | C12N 9/64 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 15/10 (2006.01), C12N 9/50 (2006.01), C12N 9/72 (2006.01) |
22 | DE application date | DAT | Jul 5, 2007 |
96 | EP application date | EAT | Jul 5, 2007 |
43 | Date of first publication | OT | Jun 22, 2016 |
| Date of publication of grant | PET | Mar 27, 2019 |
71/73 | Applicant/owner | INH | Vertex Pharmaceuticals Inc., Boston, MA, US |
72 | Inventor | IN | Madison, Edwin, San Francisco, CA 94121, US |
74 | Representative | VTR | Beetz & Partner mbB Patentanwälte, 80538 München, DE |
| Address for service | | Beetz & Partner mbB Patentanwälte, 80538 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 818804 P Jul 5, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 818910 P Jul 5, 2006
|
| Due date | FT FG | Jul 31, 2025 Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003034607 Searchable text:
EP000003034607 Original document:
EP000003034607B1 Searchable text:
EP000003034607B1 |
43 | Date of first publication | EVT | Jun 22, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Aug 5, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | May 23, 2025 (Show all update days)(Hide all update days)- May 23, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 27.03.2019: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 27.03.2019: deleted
- Aug 3, 2024
- Aug 5, 2016
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 7, 2022 |
| Issue number | HN | 50 |
| Year | PJ | 2022 |
| Publication date | VT | Dec 15, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Vertex Pharmaceuticals Inc., Boston, MA, US |
71/73 | Previous applicant/owner | INHF | Catalyst Biosciences, Inc., South San Francisco, Calif., US |
| Date of update of the procedure | REGT | Dec 15, 2022 |